make wise choices
While we are in the midst of a global psychedelic research renaissance, it’s important to know that we are still in the research phase for many of these medicines. Though many studies have produced positive results, these results have not yet led to FDA approval for traditional psychedelics. Currently, Ketamine is the only drug with psychedelic effects approved by the FDA to treat a mental health condition. MDMA is in phase 3 clinical trials and is expected to be approved in a few years. Psilocybin is potentially poised to be decriminalized much like cannabis, but is not legal anywhere in the United States at this time. Other substances like LSD are much farther from legalization due to stigma. For those considering using psychedelics as medicine, please inform yourself. The Michael Pollan talk here is a great place to start. Also, please turn to the scientific research. Here is a link to the Multidisciplinary Association of Psychedelic Studies (MAPS) catalogue of psychedelic research.
Michael Pollan wrote the premier modern book on psychedelics titled, "How To Change Your Mind.” This book is an experience of immersive journalism that is an excellent way to educate yourself on psychedelics. The views and opinions expressed by Pollan are those of the author and do not necessarily reflect the official policy or position of Athens Psychedelic Therapy.
Ketamine
Ketamine is FDA-approved for treating treatment-resistant depression. There are local Ketamine providers who can provide this medication in conjunction with our psychotherapy services. The video to the right is a news story about Ketamine from VICE.
Safety & Efficacy of Repeated Dose Intravenous Ketamine for Treatment Resistant Depression
Targeting the Glutamatergic System to Treat Major Depressive Disorder
TRIGGER WARNING: (topics of suicide and sexual assault, language, and injection imagery). The views and opinions expressed by VICE news are those of the authors and do not necessarily reflect the official policy or position of Athens Psychedelic Therapy.
Psilocybin
Below are links to some of the most well known studies using psilocybin to treat end-of-life anxiety and treatment resistant depression. The video to the right is a documentary following the first study of psilocybin for depression.
The views and opinions expressed by Real Stories are those of the authors and do not necessarily reflect the official policy or position of Athens Psychedelic Therapy.
MDMA
An organization called the Multidisciplinary Association of Psychedelic Studies (MAPS) is on a mission to achieve FDA approval for MDMA to treat PTSD. The research is sound and the FDA is cooperating by assigning MDMA “breakthrough” status. Below is a link to the 3 MDMA trials facilitated by MAPS. The video is a TED Talk given by MAPS’ founder, Rick Doblin.
The views and opinions expressed by Rick Doblin are those of the author and do not necessarily reflect the official policy or position of Athens Psychedelic Therapy.